Myopia Control
Myopia control refers to various strategies aimed at slowing down the progression of nearsightedness, or myopia, particularly in children and adolescents. With the prevalence of myopia increasing globally, effective management strategies have become increasingly important in reducing the risk of associated complications such as retinal detachment, glaucoma, and myopic maculopathy. Available treatment options for myopia control include orthokeratology (ortho-k) lenses, which are specially designed rigid gas permeable contact lenses worn overnight to reshape the cornea temporarily and correct vision during the day, thereby slowing myopia progression. Another option is atropine eye drops, which, when used at low concentrations, have been shown to slow down myopia progression by dilating the pupil and inhibiting eye growth. Additionally, multifocal or bifocal eyeglasses and contact lenses have demonstrated efficacy in managing myopia progression by altering the way light focuses on the retina. By employing these treatment options, eye care professionals can help mitigate the progression of myopia and promote better long-term eye health in individuals at risk.
Myopia control is crucial in addressing the increasing prevalence of nearsightedness, particularly in children and adolescents. Effective management strategies aim to slow down the progression of myopia, reducing the risk of associated complications. Among the available treatment options, MiSight lenses have emerged as a promising solution. These soft, daily disposable contact lenses feature a multifocal optical design, incorporating peripheral defocus management to slow down the elongation of the eyeball, a key factor in myopia development. Clinical studies have demonstrated the efficacy of MiSight lenses in reducing myopia progression by up to 59%, making them a valuable addition to myopia control strategies. With their ease of use and proven effectiveness, MiSight lenses offer a convenient and reliable option for both eye care professionals and patients seeking to manage myopia progression and promote long-term eye health.